Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL

Conclusion: PSA is a useful biomarker for predicting prognosis at levels between 20 and 70 ng / mL. However, PSA cannot be used as a prognostic factor in patients with PCa and PSA levels ≥ 70 ng / mL. When the PSA level reaches approximately 70 ng / mL, prognosis might bottom and reach a plateau.
Source: International Braz J Urol - Category: Urology & Nephrology Source Type: research